Piolax Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2015; Announces Dividend for the Second Quarter Ended September 30, 2015, Payable on December 1, 2015; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2016; Provides Dividend Guidance for the Year Ending March 31, 2016
November 08, 2015
Share
Piolax Inc. reported consolidated earnings results for the six months ended September 30, 2015. For the period, the company reported net sales of ¥31,335 million against ¥29,431 million a year ago. Operating income was ¥4,400 million against ¥4,339 million a year ago. Ordinary income was ¥4,839 million against ¥4,761 million a year ago. Net income attributable to owners of company was ¥3,446 million or ¥288.69 per share against ¥3,338 million or ¥268.36 per share a year ago. Quarterly net income before taxes and other adjustments was ¥4,839 million against ¥4,761 million a year ago.
For the second quarter ended September 30, 2015, the company announced dividend of ¥35.00 per share against ¥27.50 per share a year ago. The dividend will be payable on December 1, 2015.
For the year ending March 31, 2016, the company expects to pay term end dividend of ¥35.00 per share and full year dividend of ¥70.00 per share against term end of ¥32.50 per share and full year dividend of ¥60.00 per share a year ago.
For the year ending March 31, 2016, the company expects net sales of ¥63,000 million, operating income of ¥8,300 million, ordinary income of ¥8,800 million, net income attributable to owners of company of ¥5,900 million or ¥494.20 per share.
PIOLAX, INC. is a Japan-based company principally engaged in the manufacture and sale of automotive related products. The Company operates in two business segments. Automotive Related Business segment is mainly involved in the manufacture and sale of precision springs, industrial fasteners, as well as small unit parts that combine resin and metal to the automobile industry. Medical Equipment Business segment is involved in the manufacture and sale of interventional radiology (IVR), endoscopic treatment, and orthopedic treatment equipment to medical institutions.
Piolax Inc. Reports Consolidated Earnings Results for the Six Months Ended September 30, 2015; Announces Dividend for the Second Quarter Ended September 30, 2015, Payable on December 1, 2015; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2016; Provides Dividend Guidance for the Year Ending March 31, 2016